Literature DB >> 7864686

Persistent pulmonary lesion in a patient with rheumatoid arthritis.

F Buttgereit1, K Künzel, H J Tietz, K Sajkiewicz, K Gellert, F Hiepe, G R Burmester.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7864686      PMCID： PMC1005473          DOI： 10.1136/ard.53.12.798

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits.

Authors:  B Dupont; M Huber; S J Kim; J E Bennett
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

Review 2.  Treatment of opportunistic fungal infections.

Authors:  D Armstrong
Journal:  Clin Infect Dis       Date:  1993-01       Impact factor: 9.079

3.  [Fatal hemoptysis during bronchial aspergillosis with multiple pulmonary artery aneurysms].

Authors:  S Caulet; F Capron; J P Laaban; J Prudent; J Rochemaure; J Diebold
Journal:  Ann Pathol       Date:  1990       Impact factor: 0.407

4.  Itraconazole therapy in aspergillosis: study in 49 patients.

Authors:  B Dupont
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

5.  Nonresolving pneumonia in steroid-treated patients with obstructive lung disease.

Authors:  J Rodrigues; M S Niederman; A M Fein; P B Pai
Journal:  Am J Med       Date:  1992-07       Impact factor: 4.965

Review 6.  Fungal pneumonia in transplant recipients.

Authors:  B J Zeluff
Journal:  Semin Respir Infect       Date:  1990-03

Review 7.  Invasive external otitis caused by Aspergillus.

Authors:  P Phillips; G Bryce; J Shepherd; D Mintz
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

Review 8.  Fungal infections in cancer patients: an escalating problem.

Authors:  G Samonis; D Bafaloukos
Journal:  In Vivo       Date:  1992 Mar-Apr       Impact factor: 2.155
  8 in total
  1 in total

1.  Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy.

Authors:  Ariane Leboime; Jean-Marie Berthelot; Yannick Allanore; Lama Khalil-Kallouche; Philippe Herman; Philippe Orcel; Frédéric Lioté
Journal:  Arthritis Res Ther       Date:  2009-11-03       Impact factor: 5.156
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.